ZBH - Zimmer Biomet
107.12
| Index: | S&P 500 | P/E: | 20.41 | EPS (ttm): | 5.25 | Insider Own: | 0.14% | Shs Outstand: | 199.60M | Perf Week: | 0.36% |
| Market Cap: | 21.59B | Forward P/E: | 12.51 | EPS next Y: | 8.57 | Insider Trans: | 0.00% | Shs Float: | 198.79M | Perf Month: | -1.97% |
| Income(ttm): | 1.08B | PEG: | 3.03 | EPS next Q: | 2.30 | Inst Own: | 92.83% | Short Float: | 3.34% | Perf Quarter: | -0.42% |
| Revenue(ttm): | 7.60B | P/S: | 2.84 | EPS this Y: | 5.76% | Inst Trans: | -2.42% | Short Ratio: | 4.41 | Perf Half Y: | -1.24% |
| Book/sh: | 62.00 | P/B: | 1.73 | EPS next Y: | 7.27% | ROA: | 5.05% | Short Interest: | 6.64M | Perf Year: | -10.73% |
| Cash/sh: | 2.82 | P/C: | 37.94 | EPS next 5Y: | 6.74% | ROE: | 8.71% | 52W Range: | 101.47 - 133.90 | Perf YTD: | -11.98% |
| Dividend Est.: | 0.87 (0.81%) | P/FCF: | 19.64 | EPS past 5Y: | - | ROI: | 6.33% | 52W High: | -20.00% | Beta: | 1.02 |
| Dividend TTM: | 0.96 (0.90%) | Quick Ratio: | 0.70 | Sales past 5Y: | -1.20% | Gross Margin: | 62.71% | 52W Low: | 5.57% | ATR (14): | 2.35 |
| Dividend Ex-Date: | Dec 30, 2024 | Current Ratio: | 1.36 | EPS Y/Y TTM: | 131.89% | Oper. Margin: | 18.93% | RSI (14): | 45.84 | Volatility: | 2.68% 2.02% |
| Employees: | 18000 | Debt/Eq: | 0.52 | Sales Y/Y TTM: | 4.34% | Profit Margin: | 14.27% | Recom: | 2.48 | Target Price: | 123.56 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.38 | EPS Q/Q: | 58.38% | Payout: | 19.66% | Rel Volume: | 2.63 | Prev Close: | 105.81 |
| Sales Surprise: | 1.44% | EPS Surprise: | -0.22% | Sales Q/Q: | 4.03% | Earnings: | Oct 30 BMO | Avg Volume: | 1.51M | Price: | 107.12 |
| SMA20: | -1.59% | SMA50: | -0.73% | SMA200: | -5.01% | Undervalued: 15.35% | Volume: | 3,969,105 | Change: | 1.24% | |
Graham Classic formula value: 103.62
(P/E=8 * 1g) Min value: 69.49
(current P/E * 2g) Max value: 159.77
Average value: 110.96
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.